Shanghai Bioman Pharma Limited (Bioman) is a high-tech company dedicated to research and development of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Our services range from custom synthesis to scale-up manufacturing, from technology development to regulatory documents preparation. Dedicated to technology advancement, we are committed to meeting customer requirements with high quality products and service. Based on three major platforms of chemical synthesis, biotechnology and small molecule purification, we apply multidisciplinary techniques in the research and development of complex APIs and pharmaceutical intermediates, especially chiral products. With extensive industry experience and a multifunctional workshop for pilot trial, Bioman facilitates seamless transitions from bench-top to scale-up production.